Loading clinical trials...

An Observational Study of Patients With Chronic Kidney Disease | Clinical Trials | Clareo Health

WITHDRAWN

An Observational Study of Patients With Chronic Kidney Disease

NCT05774392•Target PharmaSolutions, Inc.

Summary

TARGET-KIDNEY is an observational research study to conduct a comprehensive review of outcomes for patients with chronic kidney disease (CKD) and end-stage renal disease (ESKD).

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Disease Cohort
•Adult\* patients at the time of enrollment with a diagnosis of CKD/ESKD by ICD-10 code in the EHR interface
•Adult \* patients diagnosed and managed for CKD/ESKD invited to participate
•Ability to provide written informed consent

Exclusion Criteria

•Death
•Manual removal (sponsor or site request)
•No EHR interface encounter \> 3 years
•Engaged Cohort
•Patient expressed desire to withdraw consent to complete PROs
•Failure to complete PROs within 24 weeks of initial invitation
•Greater than 24 months lapse of survey completion after baseline surveys completed
•Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort

Key Dates

Start Date

April 1, 2025

Primary Completion Date

April 7, 2025

Completion Date

April 7, 2025

Last Updated

December 17, 2025

Conditions

Kidney Disease, ChronicEnd Stage Kidney Disease

Interventions

Observational

OTHER

Ketoanalogue Supplementation for Muscle Protection in CKD 4 and 5 Patients With Moderately Low Protein Diet (KETO-PROT-ACTION)

NCT07374042

Kidney Disease, Chronic

View study

RECRUITINGPHASE4

Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients

NCT07271420

HypertensionPeritoneal Dialysis+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 17, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

An Observational Study of Patients With Chronic Kidney Disease

Inclusion Criteria

Exclusion Criteria

Ketoanalogue Supplementation for Muscle Protection in CKD 4 and 5 Patients With Moderately Low Protein Diet (KETO-PROT-ACTION)

Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients

Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants

Symptom Monitoring in Hemodialysis

A High Protein Egg White Pudding for People With Kidney Failure (HiPE KF)

Rutgers University Study of the Genetics of Kidney Disease